EOM Pharmaceuticals Holdings, Inc. (OTCPK: IMUC)
Health Care · Biotechnology · US
$0.10
-40.21% today · +5.7% 1Y
EOM Pharmaceuticals Holdings, Inc. (OTCPK: IMUC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $12.02M and employs 3 people.
Over the last twelve months the share price has gained 5.7%, trading between 0.02 and 0.34.
Tweenvest scores EOM Pharmaceuticals Holdings, Inc. across four factors: quality 27/100, value 25/100. Its strongest factor is quality.
IMUC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.02M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 0.20
- 52-week high
- $0.34
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 126.50M
- Employees
- 3
- Next earnings
- —
About EOM Pharmaceuticals Holdings, Inc.
EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum aminosterol with an intracellular mechanism that has completed Phase 2 clinical trial for the treatment of age-related macular degeneration, diabetic retinopathy, and macular edema due to retinal vain occlusion. EOM Pharmaceuticals Holdings, Inc. was founded in 2020 and is headquartered in Montvale, New Jersey.
- ISIN
- US4525364026
- Founded
- 2020
- Listed since
- Jan 8, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Synlogic, Inc.OTCPK: SYBX | $12.25M | $1.00 | -9.09% |
| NextCell Pharma ABOM: NXTCL | $12.20M | Skr0.96 | -5.53% |
| Radiopharm Theranostics LimitedASX: RAD | $12.07M | AU$0.00 | -20.00% |
| Pharmala Biotech Holdings Inc.CNSX: MDMA | $12.02M | CA$0.16 | -27.91% |
| Karyopharm Therapeutics Inc.NasdaqGS: KPTI | $11.74M | $0.52 | -5.27% |
| AEON Biopharma, Inc.NYSEAM: AEON | $11.57M | $0.23 | -15.94% |
| BioLineRx Ltd.TASE: BLRX | $11.56M | ₪0.01 | -7.69% |
| Eagle Pharmaceuticals, Inc.OTCPK: EGRX | $11.53M | $0.89 | -8.76% |
Figures last refreshed Oct 18, 2026.